Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 January 1993 | Volume 118 Issue 1 | Pages 1-6
Objective: To estimate by casecontrol methods the effect of screening using the fecal occult blood test (FOBT) on mortality from colorectal cancer and to examine the relation of that effect to the interval since the most recent screening test.
Design: A casecontrol study.
Setting: The Kaiser Permanente Medical Care Program of Northern California.
Patients: A total of 485 persons who developed fatal colorectal cancer after 50 years of age and 727 age- and sex-matched controls.
Measurements: History of screening FOBTs during the 5 years before case diagnosis.
Results: After adjustment for potentially confounding factors, an odds ratio of 0.69 (95% CI, 0.52 to 0.91) was observed for exposure to at least one screening FOBT during the 5-year interval. The odds ratio was lowest for the first year after the most recent FOBT and rose to 1.00 three years after the last screening examination. False-negative results among cases in the 1 to 2 years before diagnosis contributed substantially to lowering the estimate of efficacy.
Conclusions: These data suggest that a program of annual or biennial screening using FOBTs might lower population risk for mortality from colorectal cancer sufficiently to have important public health implications. However, the confidence intervals around our odds ratio estimates were wide. We therefore believe that additional data will be needed before making recommendations that FOBT screening be expanded.
Author and Article Information
From the Kaiser Permanente Medical Care Program, Oakland, California; the University of Washington School of Public Health and Community Medicine, Seattle, Washington.
ARTICLE
Effect of Fecal Occult Blood Testing on Mortality From Colorectal Cancer: A Case-Control Study
![]()
Requests for Reprints: Joe V. Selby, MD, Division of Research, Kaiser Permanente Medical Care Program, 3451 Piedmont Avenue, Oakland, CA 94611.
Acknowledgments: The authors thank Ms. May Kuwatani and Ms. Betty Jue for reviewing the medical records for this study.
Grant Support: By the National Cancer Institute, grants R01 CA 46569 and R35 CA 49761.
Related articles in Annals:
This article has been cited by other articles:
![]() |
R. K. Varghese, C. Friedman, F. Ahmed, A. L. Franks, M. Manning, and L. C. Seeff Does Health Insurance Coverage of Office Visits Influence Colorectal Cancer Testing? Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 744 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Amonkar, T. L. Hunt, Z. Zhou, and X. Jin Surveillance Patterns and Polyp Recurrence following Diagnosis and Excision of Colorectal Polyps in a Medicare Population Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 417 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Kelloff, R. L. Schilsky, D. S. Alberts, R. W. Day, K. Z. Guyton, H. L. Pearce, J. C. Peck, R. Phillips, and C. C. Sigman Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs Clin. Cancer Res., June 1, 2004; 10(11): 3908 - 3918. [Full Text] [PDF] |
||||
![]() |
T. R. Church, M. W. Yeazel, R. M. Jones, L. K. Kochevar, G. D. Watt, S. J. Mongin, J. E. Cordes, and D. Engelhard A Randomized Trial of Direct Mailing of Fecal Occult Blood Tests To Increase Colorectal Cancer Screening J Natl Cancer Inst, May 19, 2004; 96(10): 770 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
W S Atkin and J M A Northover Population based endoscopic screening for colorectal cancer Gut, March 1, 2003; 52(3): 321 - 322. [Full Text] [PDF] |
||||
![]() |
C. W. Ko, W. Kreuter, and L.-M. Baldwin Effect of Medicare Coverage on Use of Invasive Colorectal Cancer Screening Tests Arch Intern Med, December 9, 2002; 162(22): 2581 - 2586. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yee CT Screening for Colorectal Cancer RadioGraphics, November 1, 2002; 22(6): 1525 - 1531. [Full Text] [PDF] |
||||
![]() |
W. F. Anderson, K. Z. Guyton, R. A. Hiatt, S. W. Vernon, B. Levin, and E. Hawk Colorectal Cancer Screening for Persons at Average Risk J Natl Cancer Inst, August 7, 2002; 94(15): 1126 - 1133. [Full Text] [PDF] |
||||
![]() |
J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al. Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. La Vecchia Fecal occult blood screening for colorectal cancer: open issues Ann. Onc., January 19, 2002; 13(1): 31 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bleiberg Hemoccult should no longer be used for the screening of colorectal cancer Ann. Onc., January 19, 2002; 13(1): 44 - 46. [Full Text] [PDF] |
||||
![]() |
Y Niv, M Lev-El, G Fraser, G Abuksis, and A Tamir Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers Gut, January 1, 2002; 50(1): 33 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Mandel, T. R. Church, J. H. Bond, F. Ederer, M. S. Geisser, S. J. Mongin, D. C. Snover, and L. M. Schuman The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer N. Engl. J. Med., November 30, 2000; 343(22): 1603 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sonnenberg, F. Delco, and J. M. Inadomi Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer Ann Intern Med, October 17, 2000; 133(8): 573 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Johnson and A. H. Dachman CT Colonography: The Next Colon Screening Examination? Radiology, August 1, 2000; 216(2): 331 - 341. [Abstract] [Full Text] |
||||
![]() |
G. S. Gazelle, P. M. McMahon, and F. J. Scholz Screening for Colorectal Cancer Radiology, May 1, 2000; 215(2): 327 - 335. [Abstract] [Full Text] |
||||
![]() |
C D JOHNSON and D A AHLQUIST Computed tomography colonography (virtual colonoscopy): a new method for colorectal screening Gut, March 1, 1999; 44(3): 301 - 305. [Full Text] [PDF] |
||||
![]() |
J. E. Allison, I. S. Tekawa, L. J. Ransom, and A. L. Adrain A Comparison of Fecal Occult-Blood Tests for Colorectal-Cancer Screening N. Engl. J. Med., January 18, 1996; 334(3): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Toribara and M. H. Sleisenger Screening for Colorectal Cancer N. Engl. J. Med., March 30, 1995; 332(13): 861 - 867. [Full Text] [PDF] |
||||
![]() |
H. J. Sox Preventive Health Services in Adults N. Engl. J. Med., June 2, 1994; 330(22): 1589 - 1595. [Full Text] |
||||
![]() |
H. Yoshida, Y. Masutani, P. MacEneaney, D. T. Rubin, and A. H. Dachman Computerized Detection of Colonic Polyps at CT Colonography on the Basis of Volumetric Features: Pilot Study Radiology, February 1, 2002; 222(2): 327 - 336. [Abstract] [Full Text] [PDF] |
||||